Publication
Article
Pharmacy Times
Author(s):
A recent data review revealed that theantipsychotic drug trifluoperazine is welltoleratedand more effective than placebofor the short-term treatment of generalizedanxiety disorder. Researchers fromthe University Hospitals of Cleveland/Case Western Reserve University conductedthe review to determine howeffective an antipsychotic drug would bein treating anxiety. Researchers looked atstudies of bipolar disorder and majordepressive disorders that included anxiety-related changes. Keming Gao, MD, PhD, of the review team said, "We foundthat, in a well-designed study, low dosesof trifluoperazine?were well-toleratedand superior to placebo. In less welldesignedstudies, other?antipsychoticsappeared to be superior to placebo andmight be as effective as sedative drugs inthe short-term treatment of generalizedanxiety disorders." Results also showedthat, when compared with placebo, theantipsychotics olanzapine and quetiapinesignificantly reduced symptoms ofanxiety in patients with bipolar disorder.
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.